Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 20

Showing 20 citing articles:

Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 9
The Impact and Burden of Dietary Sugars on the Liver
Helaina Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 14
A Review of the Effects of Fucoxanthin on NAFLD
Nor Hafiza Sayuti, Khairul Najmi Muhammad Nawawi, Jo Aan Goon, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1954-1954
Open Access | Times Cited: 11
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy
Mengying Xia, Mahboubeh Varmazyad, Iris Plá-Palacín, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Hepatology International (2025)
Open Access
A study of correlation of the dietary index for gut microbiota with non-alcoholic fatty liver disease based on 2007–2018 National Health and Nutrition Examination Survey
Yinda Wang, Binzhong Zhang, Lianzhong Feng, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Analysis of whole-exome data of nonobese NAFLD patients from India reveals association with new markers on functionally relevant genes and pathways
Arnab Ghosh, Anamitra Barik, Rajesh Kumar, et al.
Journal of Genetics (2025) Vol. 104, Iss. 1
Closed Access
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
Jing Fang, Séverine Celton‐Morizur, Chantal Desdouets
Cancers (2023) Vol. 15, Iss. 14, pp. 3723-3723
Open Access | Times Cited: 9
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis
Cian-Ru Yang, Wen-Jen Lin, Pei-Chun Shen, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy
Mengying Xia, Mahboubeh Varmazyad, Iris Plá-Palacín, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Prevalence of GCKR rs1260326 Variant in Subjects with Obesity Associated NAFLD and T2DM: A Case-Control Study in South Punjab, Pakistan
Tayyaba Nisar, Kashan Arshad, Zahid Khorshid Abbas, et al.
Journal of Obesity (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 6
Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease
Sylwia Ziółkowska, Marcin Kosmalski, Łukasz Kołodziej, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11307-11307
Open Access | Times Cited: 5
Is liver fibrosis a risk factor for gynecological cancers?
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Genetic predisposition to metabolic dysfunction-associated fatty liver disease
А.Е. Абатуров, Anna Nikulina
CHILD`S HEALTH (2024) Vol. 19, Iss. 3, pp. 162-174
Open Access | Times Cited: 1
Erythrina subumbrans (Hassk) Merr. (Fabaceae) Inhibits Insulin Resistance in the Adipose Tissue of High Fructose-Induced Wistar Rats
Elis Susilawati, Jutti Levita, Yasmiwar Susilawati, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3825-3839
Open Access | Times Cited: 1
PEMT rs7946 Polymorphism and Sex Modify the Effect of Adequate Dietary Choline Intake on the Risk of Hepatic Steatosis in Older Patients with Metabolic Disorders
Chien‐Hsien Wu, Ting‐Yu Chang, Yen-Chu Chen, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3211-3211
Open Access | Times Cited: 2
An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review
Sanjay Bandyopadhyay, Shambo Samrat Samajdar, Sirshendu Chaudhuri, et al.
Hospital Practice (2024)
Closed Access
Genetic Predisposition of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Population-based Genome-wide Association Study
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Research Square (Research Square) (2024)
Open Access
Immunology and treatments of fatty liver disease
Sainan Tang, Shanshan Wu, Wenzhe Zhang, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 127-152
Closed Access
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, et al.
Current Drug Therapy (2023) Vol. 19, Iss. 1, pp. 20-48
Closed Access | Times Cited: 1
Phenotypic and Metabolomic Characteristics of Mouse Models of Diet-Induced Hepatic Steatosis
Cian-Ru Yang, Wen-Jen Lin, Pei-Chun Shen, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top